FIELD: medicine.
SUBSTANCE: group of inventions refers to compositions containing a nutritional composition for use in treatment or diet therapy of phenylketonuria or hyperphenylalaninemia. Use of the nutritional composition for preserving and improving the cognitive function and reducing cognitive impairment in the patients with phenylketonuria or hyperphenylalinemia, wherein said composition contains: a protein fraction, wherein the protein fraction contains less than 0.1 wt. % phenylalanine of total protein content; uridine or its equivalent; docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) or esters thereof; choline, choline salt and/or choline ester, taken in a certain ratio. Use of the composition when preparing the additive for use in diet therapy. Composition for use in food additive with dietotherapy in phenylketonuria or hyperphenylalinaemia.
EFFECT: composition described above enables extending the range of agents for use in treating or diet therapy of phenylketonuria or hyperphenylalaninemia.
14 cl, 1 dwg, 4 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
NUTRITIVE PRODUCT FOR REDUCING PHENYLALANINE LEVELS IN THE PATIENTS WITH PKU | 2016 |
|
RU2740905C2 |
METHOD FOR IMPROVING FUNCTIONAL SYNAPTIC CONNECTIVITY | 2013 |
|
RU2667968C2 |
IMPROVEMENT OF MEMORY IN PATIENTS WITH 24-26 POINTS BY MENTAL STATE MINI-EXAMINATION | 2008 |
|
RU2529815C2 |
METHOD FOR NEUROTRAUMA TREATMENT | 2012 |
|
RU2622999C2 |
METHOD FOR CONTROL FUNCTIONS IMPROVEMENT | 2012 |
|
RU2637089C2 |
METHOD FOR NEUROTRAUMA TREATMENT | 2012 |
|
RU2749191C2 |
IMPROVEMENT OF MEMORY IN PATIENTS WITH ESTIMATION OF 24-26 POINTS OF MINIMAL MENTAL STATE EXAMINATION | 2014 |
|
RU2677345C2 |
NON-MEDICAL INCREASE OR MAINTENANCE OF BODY WEIGHT OF A MAMMAL | 2011 |
|
RU2647461C2 |
COMBINATION OF COMPONENTS FOR PREVENTION AND TREATMENT OF INDISPOSITION | 2011 |
|
RU2646830C2 |
RECOGNITION IMPROVEMENT | 2012 |
|
RU2638809C2 |
Authors
Dates
2019-06-05—Published
2014-04-17—Filed